Bacterial killing by use of once daily gentamicin dosage in guinea pigs with Escherichia coli infection

American Journal of Veterinary Research

Volumn 57, Issue 11, 1996, Pages 1627-1630

  Campbell, Bonnie G ^a   Bartholow, Steven ^a   Rosin, Eberhard ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GENTAMICIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; DRUG EFFECT; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEMALE; GUINEA PIG; MALE; MICROBIOLOGY; RODENT DISEASE;

ANIMALS; ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENTAMICINS; GUINEA PIGS; MALE; RODENT DISEASES;

EID: 0030276840     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Aronson AL, Aucoin DP. Antimicrobial drugs. In: Ettinger SJ, ed. Textbook of veterinary internal medicine. 3rd ed. Philadelphia: WB Saunders Co, 1989;409.
2. Papich MG. Table of common drugs: approximate dosages. In: Kirk RW, Bonagura JD, eds. Current veterinary therapy XI small animal practice. Philadelphia: WB Saunders Co, 1992;1239.
3. Prescott JF, Baggot DJ. Antimicrobial therapy in veterinary medicine. Boston: Blackwell Scientific Publications, 1988;133.
4. Riviere EJ. The aminoglycosides. In: Johnson DE, ed. The Bristol veterinary handbook of antimicrobial therapy. 2nd ed. Veterinary Learning Systems, 1987;257.
5. Frame FT, Phair JP, Watanakunakorn C, et al. Pharmacologic factors associated with gentamicin nephrotoxicity in rabbits. J Infect Dis 1977;135:952-956.
6. Gilbert DN. Minireview. once-daily aminoglycoside therapy. Antimicrob Agents Chemother 1991;35:399-405.
7. Mattie H, Craig WA, Pechiere JC. Review: determinants of efficacy and toxicity of aminoglycosides. J Antimicrob Chemother 1989;24:281-293.
8. Reiner NE, Bloxham DD, Thompson WL. Nephrotoxicity of gentamicin and tobramycin given once daily or continuously in dogs. J Antimicrob Chemother 1978;4(Suppl A):85-101.
9. Riviere JE, Carver MP, Coppoc GL, et al. Pharmacokinetics and comparative nephrotoxicity of fixed-dose versus fixed-interval reduction of gentamicin dosage in subtotal nephrectomized dogs. Toxicol Appl Pharmacol 1987;75:496-509.
10. Blaser J, Stone BB, Zinner SH. Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model. Antimicrob Agents Chemother 1985;27;343-349.
11. Daikos GL, Jackson GG, Lolans VT, et al. Adaptive resistance to aminoglycoside antibiotics from first-exposure down regulation. J Infect Dis 1990;162:414-420.
12. Daikos GL, Lolans VT, Jackson GG. First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. Antimicrob Agents Chemother 1991;35:117-123.
13. Garrafo R, Drugeon HB, Dellamonica P, et al. Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity. Antimicrob Agents Chemother 1990;34:614-621.
14. Gerber AU, Craig WA, Brugger HP, et al. Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice. J Infect Dis 1983;147: 910-917.
15. Jackson GG, Lolans VT, Daikos GL. The inductive role of ionic binding in the bactericidal and postexposure effects of aminoglycoside antibiotics with implications for dosing. J Infect Dis 1990;162:408-413.
16. Kapusnik JE, Hackbarth CJ, Chambers HF, et al. Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental Pseudomonas pneumonia. J Infect Dis 1988;158:7-12.
17. Nordstrom L, Ringberg H, Cronberg S, et al. Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity? J Antimicrob Chemother 1990;25:159-173
18. Powell SH, Thompson WL, Luthe MA, et al. Once-daily vs continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin. J Infect Dis 1988;147:918-932.
19. Leggett JE, Fantin B, Ebert S, et al. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection model. J Infect Dis 1989;159:281-292.
20. Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987;155:93-99.
21. Vogelman B, Gudmundsson S, Leggett J, et al. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal mode. J Infect Dis 1988;158:831-847.
22. Potel G, Caillon J, Fantin B, et al. Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro - in vivo correlation. Antimicrob Agents Chemother 1991;35:111-116.
23. Bennett JV, Brodie JL, Benner DJ, et al. Simplified accurate method for antibiotic assay of clinical specimens. Appl Microbiol 1966;14:170-177.
24. Amsterdam D. Susceptibility testing of antimicrobials in liquid media. In: Lorian V, ed. Antibiotics in laboratory medicine. 3rd ed. Baltimore: Williams & Wilkins, 1991;97-98.
25. Hancock RE. Aminoglycoside uptake and mode of action -with special reference to streptomycin and gentamicin. 1. Antagonist and mutants. J Antimicrob Chemother 1981;8:249-276.
26. Bryan LE, Kwan S. Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob Agents Chemother 1983;23:835-845.
27. Vogelman BS, Craig WA. Postantibiotic effects. J Antimicrob Chemother 1985;15:37-46.
28. Mackenzie FM, Gould IM. Review: the post-antibiotic effect. J Antimicrob Chemother 1993:32:519-537.
29. Barmada S, Kohlhepp S, Leggett J, et al. Correlation of tobramycin-induced inhibition of protein synthesis with postantibiotic effect in Escherichia coli. Antimicrob Agents Chemother 1993;37: 2678-2683.
30. Hanberger H Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect, and effective regrowth time. Scand J Infect Dis Suppl 1992;81:l-52.
31. Karlowsky JA, Zhanel GG, Davidson RJ, et al. Postantibiotic effect on Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro. J Antimicrob Chemother 1994;33:937-947.
32. Bennett WM, Plamp CE, Gilbert DN, et al. The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. J Infect Dis 1979; 140:576-580.
33. Frazier DL, Aucoin DP, Riviere JE. Gentamicin pharmacokinetics and nephrotoxicity in naturally acquired and experimentally induced disease in dogs. J Am Vet Med Assoc 1988;192:57-63.
34. Chung M, Parravicini L, Assael B, et al. Comparative pharmacokinetics of aminoglycoside antibiotics in guinea pigs. Anfimicrob Agents Chemother 1982;22:1017-1021.
35. Herscovia L, Grise G, Thauvin C, et al. Efficacy and safety of once daily versus intermittent dosing of tobramycin in rabbits with acute pyelonephritis. Scand J Infect Dis 1988;20:205-212.
36. Wood CA, Norton DR, Kohlhepp SS, et al. The influence of tobramycin dosage regimen on nephrotoxicity, ototoxicity and antibacterial efficacy in a rat model of subcutaneous abscess. J Infect Dis 1988;158:13-22.
37. Gerber AU, Crain WA, Brugger HP, et al. Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice. J Infect Dis 1983;147: 910-917.
38. Roosendaal R, Bakker-Woudenberg IAJ, Berghe-van Raffe M, et al. Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin, and ciprofloxacin on Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats. Eur J Clin Microbiol Infect Dis 1989;8:878-887.
39. Gerber AU, Feller-Segessenmann C.- In vivo assessment of in vitro killing patterns of Pseudomonas aeruginosa. J Antimicrob Chemother 1985:15:201-206.